MW
GSK icon

Marcum Wealth’s GSK GSK Stock Holding History

Marcum Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$363K Buy
9,373
+7
+0.1% +$256 0.03% 250
2024
Q4 		$317K Buy
9,366
+591
+7% +$21.3K 0.03% 273
2024
Q3 		$359K Buy
8,775
+432
+5% +$17.7K 0.03% 241
2024
Q2 		$321K Buy
8,343
+139
+2% +$5.85K 0.03% 258
2024
Q1 		$352K Sell
8,204
-35
-0.4% -$1.44K 0.04% 242
2023
Q4 		$305K Buy
8,239
+181
+2% +$6.5K 0.03% 252
2023
Q3 		$292K Buy
+8,058
New +$286K 0.04% 245

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marcum Wealth's GSK Position: Q1 2025 in Review

Marcum Wealth increased its GSK (GSK) stake by 0.07% in Q1 2025, buying an estimated $256 and bringing the position to 9,373 shares worth $363K. The position accounts for 0.03% of the portfolio, ranked #250.

Marcum Wealth first reported a position in GSK in Q3 2023 and has held it in 7 quarters since. 858 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Marcum Wealth held 9,373 shares of GSK worth $363K as of Q1 2025.
  • Marcum Wealth bought 7 GSK shares in Q1 2025, an estimated $256.
  • GSK made up 0.03% of Marcum Wealth's portfolio in Q1 2025, its #250 holding.
  • Marcum Wealth first reported a position in GSK in Q3 2023 and has held it in 7 quarters since.
  • 858 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Marcum Wealth's 13F filing for Q1 2025, filed 2 Apr 2025.